Explore
Search ClinicalTrials.gov
Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.
Results matching your filters
Sponsor: Ambros Therapeutics, Inc.
Complex Regional Pain Syndrome Type I
United States
Sponsor: Novartis Pharmaceuticals
Primary Immune Thrombocytopenia (ITP) · Primary Evans Syndrome (ES)
United States
- A Study to Assess the Efficacy and Safety of Efgartigimod PH20 SC in Adults With Systemic SclerosisRecruiting
Sponsor: argenx
Systemic Sclerosis (SSc)
United States, Argentina, Belgium, Bulgaria, Chile +19 more
Sponsor: National Cancer Institute (NCI)
Carcinoma, Neuroendocrine · Tumor, Neuroendocrine · Tumors, Neuroendocrine · Neuroendocrine; Carcinoma
United States
Sponsor: Merck Sharp & Dohme LLC
Crohn's Disease
United States, Australia, Austria, Belgium, Brazil +42 more
Sponsor: National Cancer Institute (NCI)
Metastatic Digestive System Neuroendocrine Tumor G1 · Metastatic Digestive System Neuroendocrine Tumor G2 · Unresectable Digestive System Neuroendocrine Tumor G1 · Unresectable Digestive System Neuroendocrine Tumor G2
United States, Canada
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Endocrine Diseases
United States
Sponsor: Renmin Hospital of Wuhan University
Atrial Fibrillation (AF) · Cardiovascular Diseases
China
Sponsor: National Cancer Institute (NCI)
Pheochromocytoma · Paraganglioma · Neuroendocrine Tumors · Neuroendocrine Neoplasms
United States
Sponsor: Johns Hopkins University
Hypertension
Bangladesh
- A Study of 36-Week Refill Exchanges of Port Delivery System (PDS) With Ranibizumab in nAMDRecruiting
Sponsor: Hoffmann-La Roche
Neovascular Age-related Macular Degeneration
Austria, Czechia, Denmark, France, Germany +8 more
- Three-Dimensional Molds Based on Radiological imagEs in Patients With Cancer: the DIRECT TrialRecruiting
Sponsor: Tampere University Hospital
Cancer · Tumor
Finland
- A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's DiseaseRecruiting
Sponsor: Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)
Inflammatory Bowel Diseases · Crohn's Disease
United States, Australia, Austria, Bosnia and Herzegovina, Brazil +23 more
- Imeroprubart in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)Recruiting
Sponsor: Immunovant Sciences GmbH
Chronic Inflammatory Demyelinating Polyneuropathy
United States, Argentina, Australia, Austria, Belgium +25 more
Sponsor: Merck Sharp & Dohme LLC
Carcinoma, Non-Small-Cell Lung
United States, Argentina, Australia, Belgium, Brazil +26 more
Sponsor: Atsena Therapeutics Inc.
X-linked Retinoschisis
United States, United Kingdom
Sponsor: M.D. Anderson Cancer Center
Gastrostomy · Gastric · GastroEsophageal Cancer
United States, Japan, South Korea
Sponsor: NMD Pharma A/S
Myasthenia Gravis · Myasthenia Gravis, MuSK
United States, Belgium, Denmark, France, Georgia +5 more
Sponsor: 4D Molecular Therapeutics
Neovascular (Wet) Age-Related Macular Degeneration
United States, Puerto Rico
Sponsor: Indiana University
Snoring · Obstructive Sleep Apnea
United States
Sponsor: 115 People's Hospital
Stroke, Acute Ischemic · Large Vessel Occlusion · Thrombectomy
Vietnam
Sponsor: Wuerzburg University Hospital
Multiple Myeloma · GI Cancer · Taste Disorders
Germany
Sponsor: Lighthouse Pharmaceuticals, Inc.
Alzheimer Disease · Alzheimer Disease Due to P. Gingivalis
United States
Sponsor: Boehringer Ingelheim
Small Cell Lung Carcinoma (SCLC) · Neuroendocrine Neoplasms
Netherlands
Sponsor: UCB Biopharma SRL
Systemic Lupus Erythematosus
United States, Argentina, Belgium, Canada, Chile +17 more